These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples. Pihikova D; Kasak P; Kubanikova P; Sokol R; Tkac J Anal Chim Acta; 2016 Aug; 934():72-9. PubMed ID: 27506346 [TBL] [Abstract][Full Text] [Related]
3. Immunosensing prostate-specific antigen: Faradaic vs non-Faradaic electrochemical impedance spectroscopy analysis on interdigitated microelectrode device. Ibau C; Arshad MKM; Gopinath SCB; Nuzaihan M N M; Fathil MFM; Shamsuddin SA Int J Biol Macromol; 2020 Nov; 162():1924-1936. PubMed ID: 32822729 [TBL] [Abstract][Full Text] [Related]
4. An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis. Ishikawa T; Yoneyama T; Tobisawa Y; Hatakeyama S; Kurosawa T; Nakamura K; Narita S; Mitsuzuka K; Duivenvoorden W; Pinthus JH; Hashimoto Y; Koie T; Habuchi T; Arai Y; Ohyama C Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241428 [TBL] [Abstract][Full Text] [Related]
5. Sweet characterisation of prostate specific antigen using electrochemical lectin-based immunosensor assay and MALDI TOF/TOF analysis: Focus on sialic acid. Pihikova D; Pakanova Z; Nemcovic M; Barath P; Belicky S; Bertok T; Kasak P; Mucha J; Tkac J Proteomics; 2016 Dec; 16(24):3085-3095. PubMed ID: 26920336 [TBL] [Abstract][Full Text] [Related]
6. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396 [TBL] [Abstract][Full Text] [Related]
8. Gold interdigitated triple-microelectrodes for label-free prognosticative aptasensing of prostate cancer biomarker in serum. Ibau C; Md Arshad MK; Gopinath SCB; Nuzaihan M N M; M Fathil MF; Estrela P Biosens Bioelectron; 2019 Jul; 136():118-127. PubMed ID: 31054519 [TBL] [Abstract][Full Text] [Related]
9. The electrochemical immunosensor for detection of prostatic specific antigen using quince seed mucilage-GNPs-SNPs as a green composite. Darvishi E; Ehzari H; Shahlaei M; Behbood L; Arkan E Bioelectrochemistry; 2021 Jun; 139():107744. PubMed ID: 33517204 [TBL] [Abstract][Full Text] [Related]
10. NanoMonitor: a miniature electronic biosensor for glycan biomarker detection. Nagaraj VJ; Aithal S; Eaton S; Bothara M; Wiktor P; Prasad S Nanomedicine (Lond); 2010 Apr; 5(3):369-78. PubMed ID: 20394531 [TBL] [Abstract][Full Text] [Related]
11. Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core. Bertok T; Lorencova L; Hroncekova S; Gajdosova V; Jane E; Hires M; Kasak P; Kaman O; Sokol R; Bella V; Eckstein AA; Mosnacek J; Vikartovska A; Tkac J Biosens Bioelectron; 2019 Apr; 131():24-29. PubMed ID: 30798249 [TBL] [Abstract][Full Text] [Related]
12. Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer. Llop E; Peracaula R Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876 [TBL] [Abstract][Full Text] [Related]
13. Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases. Díaz-Fernández A; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ; Estrela P Biosens Bioelectron; 2021 Mar; 175():112872. PubMed ID: 33288424 [TBL] [Abstract][Full Text] [Related]
14. Dual-modality impedimetric immunosensor for early detection of prostate-specific antigen and myoglobin markers based on antibody-molecularly imprinted polymer. Karami P; Bagheri H; Johari-Ahar M; Khoshsafar H; Arduini F; Afkhami A Talanta; 2019 Sep; 202():111-122. PubMed ID: 31171159 [TBL] [Abstract][Full Text] [Related]
15. Gold Nanoparticles-MWCNT Based Aptasensor for Early Diagnosis of Prostate Cancer. Alnaimi A; Al-Hamry A; Makableh Y; Adiraju A; Kanoun O Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551097 [TBL] [Abstract][Full Text] [Related]
16. A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer. Hassani S; Salek Maghsoudi A; Rezaei Akmal M; Rahmani SR; Sarihi P; Ganjali MR; Norouzi P; Abdollahi M J Pharm Pharm Sci; 2020; 23():243-258. PubMed ID: 32649855 [TBL] [Abstract][Full Text] [Related]
17. An ultrasensitive and disposable electrochemical aptasensor for prostate-specific antigen (PSA) detection in real serum samples. Özyurt C; Uludağ İ; Sezgintürk MK Anal Bioanal Chem; 2023 Mar; 415(6):1123-1136. PubMed ID: 36155829 [TBL] [Abstract][Full Text] [Related]
18. Glycosylated biomarker sensors: advancements in prostate cancer diagnosis. Abd Rahman SF; Md Arshad MK; Gopinath SCB; Fathil MFM; Sarry F; Ibau C Chem Commun (Camb); 2021 Sep; 57(76):9640-9655. PubMed ID: 34473143 [TBL] [Abstract][Full Text] [Related]
19. Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins. Belicky S; Černocká H; Bertok T; Holazova A; Réblová K; Paleček E; Tkac J; Ostatná V Bioelectrochemistry; 2017 Oct; 117():89-94. PubMed ID: 28651174 [TBL] [Abstract][Full Text] [Related]
20. Highly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: application as cancer biomarker for prostate biopsies. Salimi A; Kavosi B; Fathi F; Hallaj R Biosens Bioelectron; 2013 Apr; 42():439-46. PubMed ID: 23235113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]